IL111975A - Side chain-modified 1alpha - hydroxy vitamin d3 analogues process for their preparation and pharmaceutical compositions containing them - Google Patents
Side chain-modified 1alpha - hydroxy vitamin d3 analogues process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL111975A IL111975A IL11197594A IL11197594A IL111975A IL 111975 A IL111975 A IL 111975A IL 11197594 A IL11197594 A IL 11197594A IL 11197594 A IL11197594 A IL 11197594A IL 111975 A IL111975 A IL 111975A
- Authority
- IL
- Israel
- Prior art keywords
- group
- formula
- pct
- side chain
- compound
- Prior art date
Links
- OFHCOWSQAMBJIW-AVJTYSNKSA-N alfacalcidol Chemical class C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C OFHCOWSQAMBJIW-AVJTYSNKSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- 229930003316 Vitamin D Natural products 0.000 abstract 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 2
- 125000001931 aliphatic group Chemical group 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 235000019166 vitamin D Nutrition 0.000 abstract 2
- 239000011710 vitamin D Substances 0.000 abstract 2
- -1 vitamin D amine Chemical class 0.000 abstract 2
- 229940046008 vitamin d Drugs 0.000 abstract 2
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000004450 alkenylene group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000004419 alkynylene group Chemical group 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 230000000668 effect on calcium Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 230000000640 hydroxylating effect Effects 0.000 abstract 1
- 230000004060 metabolic process Effects 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 239000000376 reactant Substances 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
- 150000003710 vitamin D derivatives Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Nutrition Science (AREA)
- Urology & Nephrology (AREA)
- Physical Education & Sports Medicine (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939325415A GB9325415D0 (en) | 1993-12-13 | 1993-12-13 | Chemical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL111975A true IL111975A (en) | 1999-07-14 |
Family
ID=10746493
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11197594A IL111975A (en) | 1993-12-13 | 1994-12-13 | Side chain-modified 1alpha - hydroxy vitamin d3 analogues process for their preparation and pharmaceutical compositions containing them |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5786347A (cs) |
| EP (1) | EP0734376B1 (cs) |
| JP (1) | JP3779991B2 (cs) |
| KR (1) | KR100399661B1 (cs) |
| CN (1) | CN1080718C (cs) |
| AT (1) | ATE196468T1 (cs) |
| AU (1) | AU681223B2 (cs) |
| CA (1) | CA2178090A1 (cs) |
| CZ (1) | CZ291623B6 (cs) |
| DE (1) | DE69425980T2 (cs) |
| DK (1) | DK0734376T3 (cs) |
| ES (1) | ES2149957T3 (cs) |
| FI (1) | FI112360B (cs) |
| GB (1) | GB9325415D0 (cs) |
| GR (1) | GR3035028T3 (cs) |
| HU (1) | HU223469B1 (cs) |
| IL (1) | IL111975A (cs) |
| NO (1) | NO313800B1 (cs) |
| NZ (1) | NZ277086A (cs) |
| PT (1) | PT734376E (cs) |
| WO (1) | WO1995016672A1 (cs) |
| ZA (1) | ZA949921B (cs) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19619036A1 (de) * | 1996-04-30 | 1997-11-13 | Schering Ag | Neue Vitamin D-Derivate mit carbo- oder heterocyclischen Substituenten an C-25, Verfahren zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln |
| EP1011683A4 (en) * | 1997-05-22 | 2003-06-11 | Cephalon Inc | Vitamin d analogues and their neuronal effects |
| US6043385A (en) * | 1997-12-16 | 2000-03-28 | Hoffman-La Roche Inc. | Vitamin D derivatives |
| DE19935771A1 (de) | 1999-07-23 | 2001-02-01 | Schering Ag | Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln |
| US6989377B2 (en) | 1999-12-21 | 2006-01-24 | Wisconsin Alumni Research Foundation | Treating vitamin D responsive diseases |
| US6358939B1 (en) | 1999-12-21 | 2002-03-19 | Northern Lights Pharmaceuticals, Llc | Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease |
| ATE469907T1 (de) | 2000-10-02 | 2010-06-15 | Univ Emory | Triptolid-analoga zur behandlung von autoimmunkranheiten und entzündungen |
| WO2005027928A1 (en) * | 2003-09-19 | 2005-03-31 | Pfizer Products Inc. | 2-alkylidene-19-nor-vit amin d derivatives for the treatment of hypocalcemic tetany or hyproparathyroidism |
| TW200714580A (en) * | 2005-10-14 | 2007-04-16 | Formosa Lab Inc | Process for preparing vitamin D analogs |
| WO2010088304A1 (en) | 2009-01-27 | 2010-08-05 | Cytotech Labs, Llc | Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy |
| MX366076B (es) | 2009-08-14 | 2019-06-27 | Berg Llc | Vitamina d3 y analogos de la misma para tratar alopecia. |
| US8987235B2 (en) | 2011-05-17 | 2015-03-24 | Wisconsin Alumni Research Foundation | N-cyclopropyl-(20R)-2-methylene-19,26,27-trinor-25-aza-vitamin D analogs and their uses |
| US8785603B2 (en) | 2011-05-20 | 2014-07-22 | Siemens Healthcare Diagnostics Inc. | Antibodies to 25-hydroxyvitamin D2 and D3 and uses thereof |
| US9244083B2 (en) | 2012-11-30 | 2016-01-26 | Siemens Healthcare Diagnostics Inc. | Compositions and methods for detecting vitamin D |
| US9618523B2 (en) | 2013-02-28 | 2017-04-11 | Siemens Healthcare Diagnostics Inc. | Methods and reagents for determining isomeric analytes |
| SG10201709894RA (en) | 2013-05-29 | 2018-01-30 | Berg Llc | Preventing or mitigating chemotherapy induced alopecia using vitamin d |
| WO2019232095A1 (en) * | 2018-05-30 | 2019-12-05 | Translate Bio, Inc. | Vitamin cationic lipids |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL171580B1 (pl) * | 1991-11-07 | 1997-05-30 | Res Inst Medicine Chem | Sposób wytwarzania nowych analogów witaminy D3 PL PL PL |
| JPH06107625A (ja) * | 1992-01-13 | 1994-04-19 | Asahi Chem Ind Co Ltd | 新規な１α、２５−ジヒドロキシビタミンＤ誘導体、およびその製造法 |
-
1993
- 1993-12-13 GB GB939325415A patent/GB9325415D0/en active Pending
-
1994
- 1994-12-13 CA CA002178090A patent/CA2178090A1/en not_active Abandoned
- 1994-12-13 KR KR1019960703082A patent/KR100399661B1/ko not_active Expired - Fee Related
- 1994-12-13 ZA ZA949921A patent/ZA949921B/xx unknown
- 1994-12-13 AT AT95902896T patent/ATE196468T1/de not_active IP Right Cessation
- 1994-12-13 DK DK95902896T patent/DK0734376T3/da active
- 1994-12-13 NZ NZ277086A patent/NZ277086A/en unknown
- 1994-12-13 AU AU12158/95A patent/AU681223B2/en not_active Ceased
- 1994-12-13 US US08/652,597 patent/US5786347A/en not_active Expired - Fee Related
- 1994-12-13 DE DE69425980T patent/DE69425980T2/de not_active Expired - Fee Related
- 1994-12-13 CN CN94194822A patent/CN1080718C/zh not_active Expired - Fee Related
- 1994-12-13 HU HU9601622A patent/HU223469B1/hu not_active IP Right Cessation
- 1994-12-13 CZ CZ19961704A patent/CZ291623B6/cs not_active IP Right Cessation
- 1994-12-13 EP EP95902896A patent/EP0734376B1/en not_active Expired - Lifetime
- 1994-12-13 ES ES95902896T patent/ES2149957T3/es not_active Expired - Lifetime
- 1994-12-13 JP JP51660195A patent/JP3779991B2/ja not_active Expired - Fee Related
- 1994-12-13 WO PCT/GB1994/002725 patent/WO1995016672A1/en active IP Right Grant
- 1994-12-13 PT PT95902896T patent/PT734376E/pt unknown
- 1994-12-13 IL IL11197594A patent/IL111975A/xx not_active IP Right Cessation
-
1996
- 1996-06-12 FI FI962440A patent/FI112360B/fi not_active IP Right Cessation
- 1996-06-12 NO NO19962479A patent/NO313800B1/no not_active IP Right Cessation
-
2000
- 2000-12-12 GR GR20000402715T patent/GR3035028T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NO962479L (no) | 1996-08-12 |
| NO313800B1 (no) | 2002-12-02 |
| DK0734376T3 (da) | 2000-12-11 |
| US5786347A (en) | 1998-07-28 |
| CN1080718C (zh) | 2002-03-13 |
| GB9325415D0 (en) | 1994-02-16 |
| ES2149957T3 (es) | 2000-11-16 |
| AU1215895A (en) | 1995-07-03 |
| FI962440A0 (fi) | 1996-06-12 |
| CZ291623B6 (cs) | 2003-04-16 |
| NZ277086A (en) | 1997-04-24 |
| ATE196468T1 (de) | 2000-10-15 |
| CA2178090A1 (en) | 1995-06-22 |
| WO1995016672A1 (en) | 1995-06-22 |
| GR3035028T3 (en) | 2001-03-30 |
| DE69425980T2 (de) | 2001-02-08 |
| EP0734376B1 (en) | 2000-09-20 |
| ZA949921B (en) | 1995-10-12 |
| DE69425980D1 (de) | 2000-10-26 |
| PT734376E (pt) | 2000-12-29 |
| EP0734376A1 (en) | 1996-10-02 |
| AU681223B2 (en) | 1997-08-21 |
| HUT75515A (en) | 1997-05-28 |
| KR100399661B1 (ko) | 2004-04-30 |
| FI962440A7 (fi) | 1996-06-12 |
| HU9601622D0 (en) | 1996-08-28 |
| FI112360B (fi) | 2003-11-28 |
| JPH09511224A (ja) | 1997-11-11 |
| CZ170496A3 (en) | 1997-02-12 |
| NO962479D0 (no) | 1996-06-12 |
| HU223469B1 (hu) | 2004-07-28 |
| JP3779991B2 (ja) | 2006-05-31 |
| CN1141625A (zh) | 1997-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL111975A (en) | Side chain-modified 1alpha - hydroxy vitamin d3 analogues process for their preparation and pharmaceutical compositions containing them | |
| IL109595A (en) | Vitamin d amide derivatives | |
| CA2143636A1 (en) | Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants | |
| ATE243688T1 (de) | Taxol derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| HUT73846A (en) | Vitamin d3 analogues with a modified side chain at 17-position, process for producing them and pharmaceutical compositions | |
| NZ506139A (en) | Cholenic acid amides and pharmaceutical compositions thereof | |
| AU1956095A (en) | Vitamin-d amide derivatives | |
| TW334434B (en) | Novel quinazoline compound and anti-tumor agent | |
| DE69939106D1 (de) | Verfahren zur Herstellung von ED-71 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| FF | Patent granted | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |